This website contains information concerning Oncolytics Biotech Inc. (the "Company") that may be useful to its customers, employees and shareholders as well as the general public. The Company makes no representations or warranties as to the accuracy of any information contained on this website. Further, the Company expressly disclaims any obligation to update or correct information contained on the website and explicitly disclaims any duty to do so. The Company assumes no liability or responsibility for any errors or omissions in the content of this website.

This website contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements provided include the Company's current expectations or forecasts of future events. Generally, you can identify these statements by the fact that they use words such as "anticipate,""estimate," expect,""project,""intend,""plan,""believe," and other words and terms of similar meaning. In particular, these may include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expected progress in clinic trials, expenses, the outcome of contingencies such as legal proceedings, and financial results. From time to time, the Company also may provide oral or written forward-looking statements in other materials released to the public. Any or all of the Company's forward-looking statements contained in this website and in any other public statements may turn out to be wrong. Inaccurate assumptions made by the Company and known or unknown risks and uncertainties can affect the Company's forward-looking statements. Consequently, no forward-looking statement can be guaranteed and actual results may differ materially from those expressed or implied by the Company's forward-looking statements. Among the factors that could cause actual results to differ materially are the following: history of losses and uncertainty of future profitability; ability to raise sufficient additional capital; dependence on licensed technology; the safety and efficacy of REOLYSIN® as a cancer treatment; the success and timely completion of future clinical studies and trials; ability to successfully commercialize REOLYSIN®; uncertainties related to the research and development of pharmaceuticals; uncertainties related to the regulatory process; general changes to the economic environment; identification of side effects after products are on the market; competition; lawsuits and exposure to product liability claims; ability to attract and retain key employees and consultants; and other factors contained in the Company's reports filed with the United States Securities and Exchange Commission. Each forward-looking statement contained on the website represents the Company's judgment as of the date such statement was posted on the website or is otherwise dated. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise."